Tags

Type your tag names separated by a space and hit enter

Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    1 UBN/PRAXIS, Berlin, Germany.

    ,

    1 UBN/PRAXIS, Berlin, Germany.

    ,

    1 UBN/PRAXIS, Berlin, Germany.

    ,

    2 Infektiologikum Frankfurt, Frankfurt, Germany.

    ,

    3 MVZ Ärzteforum Seestrasse, Berlin, Germany.

    ,

    4 MVZ Karlsplatz, HIV Research and Clinical Care Centre, Munich, Germany.

    ,

    5 MSD Germany, Medical Affairs, Haar, Germany.

    5 MSD Germany, Medical Affairs, Haar, Germany.

    Source

    International journal of STD & AIDS 30:7 2019 Jun pg 727-728

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    31112487

    Citation

    Naumann, U, et al. "Safety Analysis of German Real-life Cohort WIP Shows Rates of Neuropsychiatric Events Leading to Discontinuation of Raltegravir Therapy Below 2." International Journal of STD & AIDS, vol. 30, no. 7, 2019, pp. 727-728.
    Naumann U, Moll A, Schleehauf D, et al. Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2. Int J STD AIDS. 2019;30(7):727-728.
    Naumann, U., Moll, A., Schleehauf, D., Lutz, K. T., Schmidt, W., Jaeger, H., ... Witte, V. (2019). Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2. International Journal of STD & AIDS, 30(7), pp. 727-728. doi:10.1177/0956462418812642.
    Naumann U, et al. Safety Analysis of German Real-life Cohort WIP Shows Rates of Neuropsychiatric Events Leading to Discontinuation of Raltegravir Therapy Below 2. Int J STD AIDS. 2019;30(7):727-728. PubMed PMID: 31112487.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2. AU - Naumann,U, AU - Moll,A, AU - Schleehauf,D, AU - Lutz,K T, AU - Schmidt,W, AU - Jaeger,H, AU - Funke,B, AU - Witte,V, PY - 2019/5/22/entrez PY - 2019/5/22/pubmed PY - 2019/5/22/medline SP - 727 EP - 728 JF - International journal of STD & AIDS JO - Int J STD AIDS VL - 30 IS - 7 SN - 1758-1052 UR - https://www.unboundmedicine.com/medline/citation/31112487/Safety_analysis_of_German_real-life_cohort_WIP_shows_rates_of_neuropsychiatric_events_leading_to_discontinuation_of_raltegravir_therapy_below_2 L2 - http://journals.sagepub.com/doi/full/10.1177/0956462418812642?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -